Search for: "ACTAVIS, INC." Results 141 - 160 of 382
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jun 2019, 1:19 am by Jani Ihalainen
Put differently, an inventive step (a necessary component for being able to patent something) cannot include something that is 'obvious' to a person skilled in the art, having considered anything that forms the state of the art in which they are skilled in.Typically the courts follow two tests on determining obviousness; (i) the Windsurfing/Pozzolli structure; and (ii) the EPO's problem-and-solution method.The question of obviousness, as set out in Conor Medsystems Inc v… [read post]
29 Jun 2015, 9:36 am
A futuristic Neil imagines a time when consumers’ psychological/neurological associations could be measured (also) for the sake of assess a trade marks’ reputation* Case management decisions in the Lyrica caseThe ongoing case between Warner-Lambert (a subsidiary of Pfizer) and Actavis concerning pregabalin (sold by Pfizer under the trade mark Lyrica, and by Actavis under the trade mark Lecaent) seems set to be the case of the year, Darren says. [read post]
3 Aug 2009, 7:29 am
All responding defendants (Actavis, Inc.; Actavis-Elizabeth, L.L.C.; Barr Pharmaceuticals, Inc.; Baxter Healthcare Corp.; Duramed Pharmaceuticals, Inc.; Pliva, Inc.; Pliva USA, Inc.; Schwarz Pharma, Inc.; Teva Pharmaceuticals USA, Inc.; and Wyeth) opposed centralization, as did one Plaintiff from Vermont. [read post]
26 Jan 2012, 6:57 am by Dan Hargrove
The CEO of Actavis, Inc. had this to say: “Actavis will continue to report our product pricing in an [sic] manner consistent with all applicable laws as well as the terms of this agreement. [read post]
31 Dec 2009, 2:34 am by Sean Wajert
Actavis Group hf., et al., 2:09-cv-00768 Readers may recall that the federal Digitek product liability cases, alleging that Actavis Totowa LLC, Actavis Inc. and Actavis Elizabeth LLC released Digitek tablets containing more than the appropriate dosage to the public in 2008, were transferred to an MDL  last August. [read post]
5 May 2014, 8:28 am by Gene Quinn
On April 24, 2014, Actavis announced that it has entered into an agreement with Pfizer, Inc. [read post]
17 Feb 2016, 12:19 am
Always a fan of a case management decision, the AmeriKat was interested to see the decision in Celltrion Inc. v Biogen Idec Inc., F. [read post]
21 Mar 2015, 6:26 am by Lawrence B. Ebert
Actavis plc (NYSE:ACT), No. 1:14-cv-00882 (D. [read post]
12 Dec 2013, 7:12 am
 In the meantime, here they are in outline:Case C‑443/12, Actavis Group PTC EHF, Actavis UK Ltd v Sanofi, Sanofi Pharma Bristol-Myers Squibb SNC intervening, noted on The SPC Blog here. [read post]
16 Jun 2015, 6:00 am
Actavis, the Supreme Court confirmed that reverse payments can violate the antitrust laws. [read post]
16 Jan 2011, 9:48 pm
The manufacturers that filed the appeals case were: Teva Pharmaceutical Industries, Mylan Inc.'s UDL Laboratories and Actavis Inc. [read post]
20 Jun 2008, 6:13 pm
The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. [read post]
6 Feb 2019, 4:27 am
This was summarised by HHJ Hacon as a "basic principle of patent law in the United Kingdom" and cited Merrell Dow Pharmaceutical Inc v H. [read post]
26 Mar 2013, 5:17 pm by Prashant Reddy
Actavis, Inc:  A Quick Look into Reverse Paymentsby George YuThe name of the game in the pharmaceutical industry is exclusivity. [read post]